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Estrogen Receptor Activation of CaM Kinase I and ERK 
Mikayla S. Todd and John M. Schmitt 
Biology, George Fox University, Newberg, OR 
Cell growth and development is regulated by the cell signaling second messenger, 
calcium, that regulates key enzymes and genes in cells including the 
Calcium/Calmodulin-dependent protein kinases (CaM Ks) and their downstream target 
ERK. In particular, CaM KK and its substrate CaM KI promote ERK and Elk-1 activation in 
MCF-7 breast cancer cells. Estrogen (E2) may utilize CaM KK and ERK to promote breast 
cancer cell proliferation, however it is unclear which E2 receptor promotes cell 
proliferation through CaM Ks. Estrogen is a ligand for estrogen receptors (ER) of the 
alpha(α) and beta(β) forms, as well as G protein-coupled receptor 30 (GPR30). E2 has 
recently been shown to activate ERα and GPR30 leading to ERK activation however 
transgenic mice and cells that express only a membrane localized form of ERα are 
capable of activating ERK. The precise ER that is responsible for activating CaM KI and 
ERK in MCF-7 breast cancer cells remains unknown. Our goal was to evaluate which 
estrogen receptor controls the calcium-mediated activation of CaM KI and ERK in MCF-7 
cells. E2 stimulation of MCF-7 cells potently stimulated both CaM KI and ERK 
phosphorylation, an effect that was blocked by the selective ERα inhibitor, MPP. MPP 
did not block epidermal growth factor activation of ERK. In contrast, the GPR30 
antagonist, G15, did not block E2 stimulation of CaM KI or ERK. These results suggest 
that E2 is capable of activating CaM KI and ERK through ERα but not GPR30 in MCF-7 
cells. 
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